Response to “Pharmacogenetics of Voriconazole: CYP2C19 but Also CYP3A4 Need to Be Genotyped” - The Role of CYP3A4 and CYP3A5 Polymorphisms in Clinical Pharmacokinetics of Voriconazole

T. J. Walsh; B. Moriyama; S. R. Penzak; T. E. Klein; K. E. Caudle

doi:10.1002/cpt.681

Response to “Pharmacogenetics of Voriconazole: CYP2C19 but Also CYP3A4 Need to Be Genotyped” - The Role of CYP3A4 and CYP3A5 Polymorphisms in Clinical Pharmacokinetics of Voriconazole

T. J. Walsh, B. Moriyama, S. R. Penzak, T. E. Klein, K. E. Caudle

UNT System College of Pharmacy

Research output: Contribution to journal › Letter › peer-review

6 Scopus citations

Original language	English
Pages (from-to)	190
Number of pages	1
Journal	Clinical Pharmacology and Therapeutics
Volume	102
Issue number	2
DOIs	https://doi.org/10.1002/cpt.681
State	Published - 1 Aug 2017

Access to Document

10.1002/cpt.681

Cite this

@article{c6c6e613cee3435097312688c9e7cff0,

title = "Response to “Pharmacogenetics of Voriconazole: CYP2C19 but Also CYP3A4 Need to Be Genotyped” - The Role of CYP3A4 and CYP3A5 Polymorphisms in Clinical Pharmacokinetics of Voriconazole",

author = "Walsh, {T. J.} and B. Moriyama and Penzak, {S. R.} and Klein, {T. E.} and Caudle, {K. E.}",

year = "2017",

month = aug,

day = "1",

doi = "10.1002/cpt.681",

language = "English",

volume = "102",

pages = "190",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

publisher = "Wiley-Blackwell",

number = "2",

}

Response to “Pharmacogenetics of Voriconazole: CYP2C19 but Also CYP3A4 Need to Be Genotyped” - The Role of CYP3A4 and CYP3A5 Polymorphisms in Clinical Pharmacokinetics of Voriconazole. / Walsh, T. J.; Moriyama, B.; Penzak, S. R. et al.
In: Clinical Pharmacology and Therapeutics, Vol. 102, No. 2, 01.08.2017, p. 190.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Response to “Pharmacogenetics of Voriconazole

T2 - CYP2C19 but Also CYP3A4 Need to Be Genotyped” - The Role of CYP3A4 and CYP3A5 Polymorphisms in Clinical Pharmacokinetics of Voriconazole

AU - Walsh, T. J.

AU - Moriyama, B.

AU - Penzak, S. R.

AU - Klein, T. E.

AU - Caudle, K. E.

PY - 2017/8/1

Y1 - 2017/8/1

UR - http://www.scopus.com/inward/record.url?scp=85018952753&partnerID=8YFLogxK

U2 - 10.1002/cpt.681

DO - 10.1002/cpt.681

M3 - Letter

AN - SCOPUS:85018952753

SN - 0009-9236

VL - 102

SP - 190

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

IS - 2

ER -

Response to “Pharmacogenetics of Voriconazole: CYP2C19 but Also CYP3A4 Need to Be Genotyped” - The Role of CYP3A4 and CYP3A5 Polymorphisms in Clinical Pharmacokinetics of Voriconazole

Access to Document

Other files and links

Cite this